Form 4: Lawrence Steinman Reports Acquisition of BioAtla Stock Options

Director Lawrence Steinman reports acquisition of 16,500 shares of BioAtla, Inc. common stock via restricted stock units.

Summary

• Lawrence Steinman, a director of BioAtla, Inc., filed a Form 4 on June 14, 2024.
• The report details a transaction on June 13, 2024, where Steinman acquired 16,500 shares of BioAtla common stock.
• These shares are related to a time-based restricted stock unit (RSU) award.
• The RSU will vest as to 100% of the total number of shares on the earlier of June 13, 2025, and the next Company annual meeting of stockholders, subject to continued service.
• Following the reported transaction, Steinman beneficially owns 54,959 shares of common stock.

Sentiment

Score: 6

Explanation: The sentiment is neutral. It's a standard regulatory filing indicating insider activity, which can be interpreted as a positive sign of confidence, but it's not inherently bullish or bearish.

Positives

• The acquisition of shares by a director can be seen as a positive sign, indicating confidence in the company's future prospects.

Future Outlook

The vesting of the RSU is contingent on continued service, aligning the director's interests with the company's long-term success.

Industry Context

Form 4 filings are standard practice for reporting changes in beneficial ownership by company insiders, providing transparency to investors.

Stakeholder Impact

• Shareholders may view the director's increased stake as a positive signal.

Key Dates